N

Nan Fung Life Sciences

11 employees

Nan Fung Life Sciences a global life sciences investment platform with a long-term capital commitment from the Nan Fung Group.

Investor insights

Sectors invested in

Biotechnology18
Health Care16
Pharmaceutical7
Life Science7
Biopharma6
Medical5
Therapeutics5
ophthalmology4
Biopharmaceutical4
Medical Device3
pharmaceutical2
drug delivery2
Biotech2
Consumer Healthcare2
Ocular Solutions2
Biomarker2
Oncology2
Precision Medicine2
Omics1
Chemical1

Funding rounds participated in

$56M sweet spot round size

Most of their 20 investments are in rounds between $17M and $70M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Biotechnology
biotechnology
diagnostics
venture capital
therapeutics
medical devices

Date founded

2017

Investments made

D

DermBiont, Inc. raised $28M on December 21, 2021

Investors: Viking Global Investors, toba capital, Olive Tree Capital, Civilization Ventures, Toba Capital and Nan Fung Life Sciences

F

Fountain Therapeutics raised $15M on November 18, 2021

Investors: K G Khosla compressors and Nan Fung Life Sciences

E

Engrail Therapeutics raised $32M on August 3, 2021

Investors: Nan Fung Life Sciences

O

Oculis S.A. raised $57M on May 4, 2021

Investors: Tekla Capital Management, VI Partners AG, BioVeda China Fund, Earlybird Venture Capital, Wille Finance and Nan Fung Life Sciences

A

Arctic Vision Ltd. raised $100M on March 9, 2021

Investors: Octagon Capital Advisors, Loyal Valley Capital, Tencent and Nan Fung Life Sciences

E

Encodia, Inc. raised $75M on January 27, 2021

Investors: ARCH Venture Partners, Tao Capital Partners, Decheng Capital, Biomatics Capital, Northpond Ventures, GV and Nan Fung Life Sciences

A

Arctic Vision Ltd. raised $32M on July 13, 2020

Investors: Nan Fung Life Sciences

E

Engrail Therapeutics raised $32M on June 18, 2020

Investors: Nan Fung Life Sciences

F

Fountain Therapeutics raised $6M on February 12, 2020

Investors: K G Khosla compressors and Nan Fung Life Sciences

O

Omniome raised $60M on January 9, 2020

Investors: Decheng Capital, Biomatics Capital, ARCH Venture Partners, Domain Associates and Nan Fung Life Sciences

FAQ